SCHEMBL8637553

SCHEMBL8637553

O=C(c1ccc([N+](=O)[O-])cc1[N+](=O)[O-])N(NCCCl)NCCCl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.46
FLT1 P17948 1/20 0.45
FLT4 P35916 1/20 0.45
KDR P35968 1/20 0.45
MAPT P10636 2/20 0.45
POLB P06746 1/20 0.45
LMNA P02545 4/20 0.44
CYP1A2 P05177 1/20 0.43
SMN1; SMN2 Q16637 4/20 0.42
ALDH1A1 P00352 1/20 0.42
TP53 P04637 1/20 0.42
HPGD P15428 1/20 0.42
TSHR P16473 1/20 0.42
MAPK1 P28482 1/20 0.42
GPR35 Q9HC97 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C19 P33261 1/20 0.42
HTT P42858 1/20 0.41
KMT2A Q03164 4/20 0.40
MEN1 O00255 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nornitrogen Mustard SCHEMBL8637079 0.78 KMT2A (0.52) CES2FLT1FLT4KDRMAPT
Nornitrogen Mustard SCHEMBL8638765 0.75 KDM4E (0.49) CES2FLT1FLT4KDRMAPT
SCHEMBL8640126 0.74 MAPT (0.45) CES2FLT1FLT4KDRMAPT
SCHEMBL8637404 0.74 FLT1 (0.51) CES2FLT1FLT4KDRMAPT
SCHEMBL3126462 0.72 CES2 (0.59) CES2FLT1FLT4KDRMAPT
SCHEMBL8639694 0.72 MAPT (0.43) CES2FLT1FLT4KDRMAPT
SCHEMBL5341177 0.71 CES2 (0.63) CES2FLT1FLT4KDRMAPT
SCHEMBL1176899 0.71 CTSD (0.63) CES2FLT1FLT4KDRMAPT
SCHEMBL8641420 0.70 POLB (0.44) CES2FLT1FLT4KDRMAPT
Hydrochloric Acid SCHEMBL10973904 0.70 CES2 (0.42) CES2FLT1FLT4KDRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10183062-B2 Treatment for cancer THE UNIVERSITY OF NOTTINGHAM (GB) 2019-01-22 US claimed
WO-2015075475-A1 TREATMENT FOR CANCER THE UNIVERSITY OF NOTTINGHAM (GB) 2015-05-28 WO claimed
WO-2015075475-A1 TREATMENT FOR CANCER THE UNIVERSITY OF NOTTINGHAM (GB) 2015-05-28 WO disclosed
US-5750782-A ANTICARCINOGENIC AGENTS, ANTIHYPOXIC AGENTS, PRODRUGS CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) 1998-05-12 US disclosed